0000897069-23-001044.txt : 20230801 0000897069-23-001044.hdr.sgml : 20230801 20230801171016 ACCESSION NUMBER: 0000897069-23-001044 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221206 FILED AS OF DATE: 20230801 DATE AS OF CHANGE: 20230801 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Priebe Waldemar CENTRAL INDEX KEY: 0001678516 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39126 FILM NUMBER: 231132728 MAIL ADDRESS: STREET 1: 2575 W. BELLFORT STREET 2: SUITE 333 CITY: HOUSTON STATE: TX ZIP: 77054 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CNS Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001729427 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 822318545 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2100 WEST LOOP SOUTH STREET 2: SUITE 900 CITY: HOUSTON STATE: TX ZIP: 77027 BUSINESS PHONE: 1-800-946-9185 MAIL ADDRESS: STREET 1: 2100 WEST LOOP SOUTH STREET 2: SUITE 900 CITY: HOUSTON STATE: TX ZIP: 77027 4 1 form4.xml X0508 4 2022-12-06 true 0001729427 CNS Pharmaceuticals, Inc. CNSP 0001678516 Priebe Waldemar C/O CNS PHARMACEUTICALS, INC. 100 WEST LOOP SOUTH, SUITE 900 HOUSTON TX 77027 true true Common Stock 2022-12-06 4 S 0 5500 2.47 D 245605 I See footnote Common Stock 2022-12-07 4 S 0 5500 2.46 D 240105 I See footnote Common Stock 2022-12-08 4 S 0 5500 2.4 D 234605 I See footnote Common Stock 2022-12-09 4 S 0 2798 2.43 D 231807 I See footnote Common Stock 2023-03-10 4 S 0 5000 1.29 D 226807 I See footnote Common Stock 2023-03-13 4 S 0 5000 1.3 D 221807 I See footnote Common Stock 2023-03-14 4 S 0 5000 1.35 D 216807 I See footnote Common Stock 2023-03-15 4 S 0 5000 1.22 D 211807 I See footnote Common Stock 2023-03-16 4 S 0 5000 1.24 D 206807 I See footnote Common Stock 2023-03-17 4 S 0 5000 1.13 D 201807 I See footnote Common Stock 2023-03-20 4 S 0 5000 1.08 D 196807 I See footnote Common Stock 2023-03-21 4 S 0 5000 1.1 D 191807 I See footnote Common Stock 2023-03-22 4 S 0 5000 1.08 D 186807 I See footnote Common Stock 2023-03-23 4 S 0 10000 1.08 D 176807 I See footnote Common Stock 2023-03-24 4 S 0 5000 1.08 D 171807 I See footnote Common Stock 2023-03-27 4 S 0 5000 1.09 D 166807 I See footnote Common Stock 2023-03-28 4 S 0 10000 1.04 D 156807 I See footnote Consists of: (i) shares of common stock held by a limited liability company; and (ii) shares held by Houston Pharmaceuticals, Inc. /s/ Waldemar Priebe 2023-08-01